These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Purine metabolites in gout and asymptomatic hyperuricemia: analysis by HPLC-electrospray tandem mass spectrometry. Zhao J; Liang Q; Luo G; Wang Y; Zuo Y; Jiang M; Yu G; Zhang T Clin Chem; 2005 Sep; 51(9):1742-4. PubMed ID: 16120958 [No Abstract] [Full Text] [Related]
4. Plasma glutamine and oxypurine content in patients with gout. SEGAL S; WYNGAARDEN JB Proc Soc Exp Biol Med; 1955 Mar; 88(3):342-5. PubMed ID: 14371630 [No Abstract] [Full Text] [Related]
6. [Behavior of serum acid levels in children in comparison with adults and the incidence of purine metabolism disorders and concomitant diseases in children of families with gout]. Schröder HE; Mank H; Mende T; Heinrich JJ Z Gesamte Inn Med; 1985 Apr; 40(8):221-6. PubMed ID: 4013437 [TBL] [Abstract][Full Text] [Related]
7. [Interrelationship between purine, carbohydrate, lipid and aminoacid metabolism, in hyperuricaemia and gout (author's transl)]. Marinello E; Pompucci G; Riario-Sforza G Quad Sclavo Diagn; 1978 Mar; 14(1):1-25. PubMed ID: 284505 [TBL] [Abstract][Full Text] [Related]
9. Hypercrosslinked strong cation-exchange polymers for selective extraction of serum purine metabolites associated with gout. Xu Y; Liu J; Zhang H; Jiang M; Cao L; Zhang M; Sun W; Ruan S; Hu P Talanta; 2016 May; 151():172-178. PubMed ID: 26946024 [TBL] [Abstract][Full Text] [Related]
10. [The clinical manifestations of a purine metabolic disorder in the practice of the internist]. Mukhin NA; Balkarov IM; Maksimov NA Ter Arkh; 1994; 66(1):35-40. PubMed ID: 8146791 [No Abstract] [Full Text] [Related]
11. [Behavior of plasma and urine purines, after a purine-free diet, in normal subjects and patients with gout]. Vannoni D; Porcelli B; Di Stefano A; Pizzichini M; Leoncini R; Terzuoli L; Taddeo A; Marsini S; Morozzi G; Marcolongo R Medicina (Firenze); 1989; 9(3):295-7. PubMed ID: 2615605 [TBL] [Abstract][Full Text] [Related]
12. Purine metabolism in patients with gout: the role of lead. Miranda-Carús E; Mateos FA; Sanz AG; Herrero E; Ramos T; Puig JG Nephron; 1997; 75(3):327-35. PubMed ID: 9069456 [TBL] [Abstract][Full Text] [Related]
13. Increased formation of 5-phosphoriboxyl-1-pyrophosphate in red blood cells of some gouty patients. Hershko A; Hershko C; Mager J Isr J Med Sci; 1968; 4(5):939-44. PubMed ID: 5715482 [No Abstract] [Full Text] [Related]
14. Ultra-high performance liquid chromatography with ultraviolet and tandem mass spectrometry for simultaneous determination of metabolites in purine pathway of rat plasma. Lu JJ; Jia BJ; Yang L; Zhang W; Dong X; Li P; Chen J J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():84-92. PubMed ID: 27736691 [TBL] [Abstract][Full Text] [Related]
15. By the way, doctor. I have gout. I've read that foods high in purine can aggravate the condition. What is purine, and how can I reduce it in my diet. Robb-Nicholson C Harv Womens Health Watch; 2005 Jun; 12(10):8. PubMed ID: 16156065 [No Abstract] [Full Text] [Related]
16. [Hyperuricemia and disorders in content of amino acids-purine precursors in patients with autoimmune diseases and gout]. Nikolenko IuI; Siniachenko OV; Anan'eva MN; Nikolenko VIu; Dubiaga VV; Shchukin IN Lik Sprava; 2005 Jun; (4):34-6. PubMed ID: 16158711 [TBL] [Abstract][Full Text] [Related]
17. [Prevention and therapy of disorders of purine metabolism]. Schröder HE; Thiele P; Heidelmann G Z Gesamte Inn Med; 1982 Jul; 37(13):431-6. PubMed ID: 7136086 [TBL] [Abstract][Full Text] [Related]
18. NEW PROSPECTS IN THE TREATMENT OF GOUTY DYSPURINIA. DELBARRE F Arch Interam Rheumatol; 1964 Jun; 7():230-53. PubMed ID: 14209280 [No Abstract] [Full Text] [Related]
19. [De novo purine biosynthesis. In vitro measurement in hyperuricemia (author's transl)]. Chanard J; Kamoun P; Pleau JM; Brami M; Brunois JP; Funck-Brentano JL Nouv Presse Med; 1977 Sep; 6(29):2579-82. PubMed ID: 909738 [TBL] [Abstract][Full Text] [Related]
20. The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout. Sperling O; Wyngaarden JB; Starmer CF J Clin Invest; 1973 Oct; 52(10):2468-85. PubMed ID: 4353999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]